India Malaria Diagnostics Market is anticipated to
register a remarkable CAGR between 2024 and 2028. The high rate of malaria, the
rising cost of healthcare, and the increase in R&D activities, among others
are driving the growth of India Malaria Diagnostics Market. In recent years,
India has witnessed an ongoing increase in the number of malaria cases, with a
significant portion of the population at risk. To stop the spread of the
disease, the Indian government has been actively encouraging the use of
diagnostic tools for malaria. In order to encourage the use of malaria diagnoses,
the National Vector Borne Disease Control Programme (NVBDCP) has been
implementing several strategies into place, such as distributing rapid
diagnostic tests (RDTs) to healthcare facilities all across the nation. This in
turn is expected to support the growth of India Malaria Diagnostics Market.
The development of more precise and dependable
diagnostics for malaria has been facilitated by technological advancements. In
comparison to older diagnostic procedures like microscopy and RDTs, more recent
diagnostic procedures like PCR and Loop-Mediated Isothermal Amplification
(LAMP) are more sensitive and specific. As a result, there is a rising need for
these more recent diagnostic tests in India. With a focus on enhancing access
to healthcare in rural regions, India has recently made significant investments
in its healthcare infrastructure. This has increased the number of medical
facilities in the nation, which has in turn increased the demand for
diagnostics for malaria.
In India, awareness of the importance of malaria
treatment and early detection has grown. Numerous public health campaigns and
activities meant to inform the public about the condition have led to this. As
a result, more individuals are looking for diagnostic tests for malaria, which
has helped the malaria diagnostics market in India expand.
The market for malaria diagnostics is seeing an
increase in the use of point-of-care testing (POCT). Rapid malaria diagnosis
and treatment are made possible by POCT, which is crucial in rural settings
with potentially restricted access to diagnostic facilities. In the upcoming
years, POCT devices should become more widely available, supporting the
market's expansion. In India's market for malaria diagnostics, the private
sector is investing more and more. The rising incidence of malaria in the
nation and the rising demand for precise and dependable malaria diagnostics are
just two of the causes driving this expenditure. By encouraging innovation and
facilitating easier access to malaria diagnostics, this private sector
investment is anticipated to assist market expansion.
In India, people are becoming more and more
conscious of the significance of early malaria diagnosis and treatment. Public
health campaigns and educational initiatives are fueling this awareness and
helping to boost demand for malaria tests. As a result, the market is
anticipated to expand in the upcoming years as more people seek malaria
diagnostic tests.
Rapid diagnostic tests (RDTs) are a new advancement
in malaria diagnoses in India. Within 15 to 20 minutes, these tests can
identify the presence of malaria parasites in a patient's blood. RDTs can be
utilised even in distant locations where conventional microscopy might not be
available because they are simple to use, don't need any specialised equipment,
and are portable. Additionally, RDTs are an efficient method for diagnosing
malaria because of their high sensitivity and specificity.
However, the growth of the Indian market for malaria
diagnostics is being hampered by a number of concerns. These difficulties
include a lack of knowledge, excessive costs, a shortage of competent workers,
inadequate infrastructure, and strict regulatory laws. For many people in
India, the cost of malaria diagnostics can be a significant barrier to access.
Rapid diagnostic tests (RDTs), a type of affordable diagnostic test, are one
option, however their accuracy and dependability cannot be guaranteed in all
cases. More precise diagnostic tests, such those based on PCR, might be pricey
and may not be within the means of many people. The usage and dissemination of
malaria diagnostics in India may be hampered by infrastructure issues such
inadequate storage facilities, poor road networks, and restricted access to
energy. For instance, several diagnostic procedures demand refrigeration, which
may not be feasible in places with poor electricity supply.
Growing Prevalence of
Malaria
India's growing malaria prevalence is predicted to
increase demand for malaria diagnostics market. There will be a larger need for
precise and trustworthy diagnostic tests as more people develop the illness, in
order to make sure that patients receive the right care. The Indian market for
malaria diagnostics is anticipated to increase as a result in the upcoming
years. India
accounts for 3% of the world's malaria burden, according to the 2019 World
Malaria Report. India has the highest rate of malaria in the SEA area, although
compared to 2017, there were 49% less cases and 50.5% less fatalities due to
the disease. The incidence of malaria has decreased significantly in India
during the past few years. The good news is that India's malaria incidence has
been seeing a spectacular reduction, with cases estimated to have fallen by 24%
in 2017 compared to 2016 and 28% in 2018 compared to 2017. This decline was
also noted in the World Malaria Report.
India has made great
strides towards eliminating malaria in recent years, with the official malaria
load falling by about 66% between 2018 and 2022. Even though this progress is
commendable, there is still a long way to go before malaria is completely
eradicated because the majority of the disease's burden in WHO's South-East
Asia area still falls on India.
The rising incidence of malaria in India is
projected to increase demand for diagnostic tests for the disease as well as
encourage investment in their development. Because there is such a sizable and expanding
market for malaria diagnostics, there is a sizable opportunity for businesses
to create cutting-edge diagnostic technologies that can assist in overcoming
the difficulties connected with malaria diagnosis in India. This could involve
creating new point-of-care diagnostic tests that can be applied in environments
with limited resources or creating new molecular diagnostic assays with
enhanced sensitivity and specificity.
Technological Advancements
The technological advancements related to malaria
diagnostics in India have had a significant impact on the growth of the India
malaria diagnostics market in recent years and are expected to continue to
influence its growth in the coming years. For instance, a Tata Trusts programme called India Health Fund
(IHF), which focuses on infectious disease health outcomes, has announced
financing for two platform technologies that may be used to diagnose a variety
of diseases. The technologies being financed include a fever panel to identify
dengue, chikungunya, and malaria, as well as microscope-independent AI-enabled
diagnosis software that can be used to identify a variety of diseases. They
were created by Ameliorate Biotech Pvt Ltd and Medprime Technologies,
respectively.
Download Free Sample Report
Market
Segmentation
India Malaria
Diagnostics Market can be segmented by technology, by end user, and by region.
Based on technology, the India Malaria Diagnostics Market can be divided into Molecular
diagnostic tests, Rapid Diagnostic Test, and Others. Based on End User, the India
Malaria Diagnostics Market is divided into Hospitals & Clinics,
Diagnostic Centers, Home care, and Others. Based on region, the India Malaria
Diagnostics Market is divided into North, South, West and East India.
Market Players
Bio-Rad
Laboratories Inc., Abbott Laboratories, Roche Diagnostics India Pvt Ltd, Hologic,
Inc., Access Bio Inc, Becton Dickinson India Private Limited, Siemens
Healthineers AG, Meridian Bioscience, Inc., Sysmex India Private Limited is some
of the leading players operating in the India Malaria Diagnostics Market.
|
Attribute
|
Details
|
|
Base
Year
|
2022
|
|
Historic
Data
|
2018 – 2021
|
|
Estimated
Year
|
2023
|
|
Forecast
Period
|
2024 – 2028
|
|
Quantitative
Units
|
Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028
|
|
Report
coverage
|
Revenue
forecast, volume forecast, company share, competitive landscape, growth
factors, and trends
|
|
Segments
covered
|
By Technique
By End User
By Region
|
|
Regional
scope
|
North
India; South India; West India; East India
|
|
Key
companies profiled
|
Bio-Rad Laboratories Inc., Abbott Laboratories, Roche
Diagnostics India Pvt Ltd, Hologic, Inc., Access Bio Inc, Becton Dickinson
India Private Limited, Siemens Healthineers AG, Meridian Bioscience, Inc.,
Sysmex India Private Limited
|
|
Customization
scope
|
10%
free report customization with purchase. Addition or alteration to country,
regional & segment scope.
|
|
Pricing
and purchase options
|
Avail customized purchase options to meet your exact research
needs. Explore purchase options
|
|
Delivery
Format
|
PDF and Excel through Email (We can also provide the editable
version of the report in PPT/Word format on special request)
|
Report Scope:
In this report, India Malaria Diagnostics Market has been segmented into following
categories, in addition to the industry trends which have also been detailed
below:
- India Malaria Diagnostics Market,
By Technique:
o
Molecular diagnostic
tests
o
Rapid Diagnostic
Test
o
Others
·
India Malaria Diagnostics Market, By End User:
o
Hospitals &
Clinics
o
Diagnostic Centers
o
Home care
o
Others
Competitive Landscape
Company
Profiles: Detailed
analysis of the major companies present in India Malaria Diagnostics Market.
Available Customizations:
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to
five).
India Malaria Diagnostics Market is an upcoming report to be released
soon. If you wish an early delivery of this report or want to confirm the date
of release, please contact us at [email protected]